{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Sirolimus  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Sirolimus. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Sirolimus  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "sirolimus",
    "trial_2_text": "Sirolimus  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Sirolimus Supplement: 60 participants will take Sirolimus 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Sirolimus. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Sirolimus  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.27277493476867676,
      "64": 0.21192748844623566,
      "78": 0.20809254050254822,
      "177": 0.20655009150505066,
      "173": 0.19782939553260803,
      "17": 0.1940079629421234,
      "123": 0.1698017716407776,
      "21": 0.14738421142101288,
      "14": 0.14356890320777893,
      "20": 0.14354930818080902,
      "37": 0.13816773891448975,
      "9": 0.12724056839942932,
      "2": 0.12625570595264435,
      "228": 0.1178978979587555,
      "85": 0.10783727467060089,
      "46": 0.1077781692147255,
      "67": 0.10228999704122543,
      "114": 0.09424854815006256,
      "131": 0.09299109876155853,
      "126": 0.08871777355670929,
      "130": 0.08682360500097275,
      "49": 0.08182226121425629,
      "5": 0.08157189935445786,
      "297": 0.08140305429697037,
      "76": 0.07828671485185623,
      "86": 0.07704293727874756,
      "68": 0.07609181851148605,
      "189": 0.07507876306772232,
      "200": 0.0742349773645401,
      "104": 0.0734829232096672,
      "28": 0.07298294454813004,
      "79": 0.07120542228221893,
      "61": 0.07082518935203552,
      "139": 0.07062144577503204,
      "188": 0.06818756461143494,
      "77": 0.0679255798459053,
      "29": 0.06701982766389847,
      "147": 0.06538963317871094,
      "136": 0.06502556055784225,
      "96": 0.06457417458295822,
      "288": 0.062237948179244995,
      "144": 0.0595584474503994,
      "186": 0.05948825925588608,
      "350": 0.0587320402264595,
      "27": 0.058691028505563736,
      "30": 0.05798817798495293,
      "243": 0.057547204196453094,
      "180": 0.056469447910785675,
      "239": 0.05608581379055977,
      "151": 0.05553780496120453,
      "92": 0.05525277554988861,
      "4": 0.05456707626581192,
      "142": 0.054489098489284515,
      "211": 0.05432566627860069,
      "72": 0.054288994520902634,
      "396": 0.0538841187953949,
      "179": 0.05258415639400482,
      "122": 0.052249886095523834,
      "101": 0.05170913413167,
      "234": 0.0515889897942543,
      "269": 0.05156032368540764,
      "221": 0.0511784702539444,
      "154": 0.05069860443472862,
      "18": 0.05056284740567207,
      "1": 0.04908979684114456,
      "35": 0.04744633287191391,
      "193": 0.04578893631696701,
      "276": 0.0451752208173275,
      "75": 0.04515035077929497,
      "116": 0.04484987631440163,
      "355": 0.0441521592438221,
      "194": 0.04301857948303223,
      "132": 0.04274216294288635,
      "121": 0.04236720874905586,
      "339": 0.042330775409936905,
      "191": 0.04214932769536972,
      "249": 0.042071592062711716,
      "441": 0.04094311222434044,
      "356": 0.040316641330718994,
      "261": 0.04004143550992012,
      "82": 0.039773281663656235,
      "138": 0.03940601646900177,
      "212": 0.038160935044288635,
      "102": 0.03695844113826752,
      "99": 0.036808937788009644,
      "178": 0.0361836776137352,
      "38": 0.03611651435494423,
      "347": 0.03514260798692703,
      "69": 0.033946726471185684,
      "36": 0.03335174545645714,
      "253": 0.03313550725579262,
      "11": 0.03285956010222435,
      "22": 0.03281092643737793,
      "282": 0.03243646025657654,
      "204": 0.031997233629226685,
      "31": 0.031802281737327576,
      "33": 0.03163021430373192,
      "456": 0.03091031312942505,
      "246": 0.029070965945720673,
      "100": 0.028955673798918724
    },
    "trial_2_ae": {
      "87": 0.27277493476867676,
      "64": 0.21192748844623566,
      "78": 0.20809254050254822,
      "177": 0.20655009150505066,
      "173": 0.19782939553260803,
      "17": 0.1940079629421234,
      "123": 0.1698017716407776,
      "21": 0.14738421142101288,
      "14": 0.14356890320777893,
      "20": 0.14354930818080902,
      "37": 0.13816773891448975,
      "9": 0.12724056839942932,
      "2": 0.12625570595264435,
      "228": 0.1178978979587555,
      "85": 0.10783727467060089,
      "46": 0.1077781692147255,
      "67": 0.10228999704122543,
      "114": 0.09424854815006256,
      "131": 0.09299109876155853,
      "126": 0.08871777355670929,
      "130": 0.08682360500097275,
      "49": 0.08182226121425629,
      "5": 0.08157189935445786,
      "297": 0.08140305429697037,
      "76": 0.07828671485185623,
      "86": 0.07704293727874756,
      "68": 0.07609181851148605,
      "189": 0.07507876306772232,
      "200": 0.0742349773645401,
      "104": 0.0734829232096672,
      "28": 0.07298294454813004,
      "79": 0.07120542228221893,
      "61": 0.07082518935203552,
      "139": 0.07062144577503204,
      "188": 0.06818756461143494,
      "77": 0.0679255798459053,
      "29": 0.06701982766389847,
      "147": 0.06538963317871094,
      "136": 0.06502556055784225,
      "96": 0.06457417458295822,
      "288": 0.062237948179244995,
      "144": 0.0595584474503994,
      "186": 0.05948825925588608,
      "350": 0.0587320402264595,
      "27": 0.058691028505563736,
      "30": 0.05798817798495293,
      "243": 0.057547204196453094,
      "180": 0.056469447910785675,
      "239": 0.05608581379055977,
      "151": 0.05553780496120453,
      "92": 0.05525277554988861,
      "4": 0.05456707626581192,
      "142": 0.054489098489284515,
      "211": 0.05432566627860069,
      "72": 0.054288994520902634,
      "396": 0.0538841187953949,
      "179": 0.05258415639400482,
      "122": 0.052249886095523834,
      "101": 0.05170913413167,
      "234": 0.0515889897942543,
      "269": 0.05156032368540764,
      "221": 0.0511784702539444,
      "154": 0.05069860443472862,
      "18": 0.05056284740567207,
      "1": 0.04908979684114456,
      "35": 0.04744633287191391,
      "193": 0.04578893631696701,
      "276": 0.0451752208173275,
      "75": 0.04515035077929497,
      "116": 0.04484987631440163,
      "355": 0.0441521592438221,
      "194": 0.04301857948303223,
      "132": 0.04274216294288635,
      "121": 0.04236720874905586,
      "339": 0.042330775409936905,
      "191": 0.04214932769536972,
      "249": 0.042071592062711716,
      "441": 0.04094311222434044,
      "356": 0.040316641330718994,
      "261": 0.04004143550992012,
      "82": 0.039773281663656235,
      "138": 0.03940601646900177,
      "212": 0.038160935044288635,
      "102": 0.03695844113826752,
      "99": 0.036808937788009644,
      "178": 0.0361836776137352,
      "38": 0.03611651435494423,
      "347": 0.03514260798692703,
      "69": 0.033946726471185684,
      "36": 0.03335174545645714,
      "253": 0.03313550725579262,
      "11": 0.03285956010222435,
      "22": 0.03281092643737793,
      "282": 0.03243646025657654,
      "204": 0.031997233629226685,
      "31": 0.031802281737327576,
      "33": 0.03163021430373192,
      "456": 0.03091031312942505,
      "246": 0.029070965945720673,
      "100": 0.028955673798918724
    }
  },
  "safety": {
    "trial_1_safety": 0.26906058192253113,
    "trial_2_safety": 0.26906058192253113
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4743202030658722
  }
}